HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of wavefront optimized LASIK on higher order aberrations in myopic patients.

AbstractOBJECTIVE:
To determine mean change induced in root mean square value of higher order aberrations in myopic patients undergoing wavefront optimized laser assisted in situ keratomileusis.
METHODS:
This quasi experimental study was conducted at Armed Forces Institute of Ophthalmology, Rawalpindi, Pakistan from Jan 2014 to Dec 2014. Sixty eyes of 35 myopic patients were included in the study. All patients underwent wavefront optimized (WFO) laser assisted in situ keratomileusis (LASIK) using femtosecond laser (FM 200Wavelight technologies) and excimer laser (Ew 500Wavelight technologies). Higher order aberrations (HOAs) were measured with aberrometer (Wavelight allegro analyzer version 1073) during preoperative assessment and one month after surgery.
RESULTS:
All 35 patients ranged from 20 to 32 years with a mean age of 24 ± 3.41 years. Refractive error ranged from -1.00 to -9.50 DS with a mean spherical equivalent (SE) of -3.73 ± 1.95 before surgery and - 0.36 ± 1.50DS one month after LASIK. Uncorrected visual acuity (UCVA) was improved to 0.00 or better in all 60 eyes. An increase of 1.56 fold was observed in RMS of total HOAs. Among the HOAs, a statistically significant positive correlation was observed between spherical aberrations (4(th) order aberration) and preoperative spherical equivalent.
CONCLUSION:
In spite of excellent improvement in refractive error, significant amount of higher order aberrations were induced after WFO LASIK.
AuthorsMuhammad Saim Khan, Sadia Humayun, Aisha Fawad, Mazhar Ishaq, Sabahat Arzoo, Fawad Mashhadi
JournalPakistan journal of medical sciences (Pak J Med Sci) 2015 Sep-Oct Vol. 31 Issue 5 Pg. 1223-6 ISSN: 1682-024X [Print] Pakistan
PMID26649018 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: